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Aim: To understand the association between markers of oxidative stress and angiogenesis in relation 
to   disease  progression,  clinical   stage   and   cytological   grade   in   patho-physiology   of   prostate 
carcinoma.
Patients and Methods: Case control study comprised of 50 prostate carcinoma patients along with 
20 age and sex-matched healthy subjects as controls. Levels of malondialdehyde were measured to 
study the oxidative stress status in the study subjects. Angiogenesis was evaluated by studying the 
activity of Thymidine Phosphorylase/Platelet derived endothelial cell growth factor.
Results: The levels of markers of oxidative stress along with the activity of thymidine phosphorylase 
were found to be significantly higher in the study subjects in comparison to healthy controls. The 
results indicate oxidative stress and angiogenesis activity increase progressively with the increase in 
staging and progression of disease. 
Conclusion:  Oxidative stress and expression of angiogenesis activity points  clearly that with the 
progression of oxidative stress there is a simultaneous progression of angiogenesis in relation to 
disease  progression,  clinical  stage   and   cytological  grade   in   the   pathophysiology   of   prostate 
carcinoma.
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Cells undergo oxidative stress when levels of 
“Reactive   Oxygen   Species”   (ROS)   exceed   the 
counter-regulatory antioxidant capacity of the cells, 
either generated from elevated production and 
accumulation   of   ROS   or   from   a   diminution   in 
cellular   antioxidant   defenses.   ROS   initiate 
autocatalytic lipid peroxidation, which generates a 
large   variety   of   potential   genotoxic   breakdown 
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products, including alkoxyl radicals (LO
.), peroxyl 
radicals   (LOO
.),   and   aldehydes,   such   as 
malondialdehyde (MDA). MDA has been used for 
many years as a convenient biomarker for lipid 
peroxidation because of its facile reaction with 
thiobarbituric acid to form an intensely colored 
chromogen   (Janero,1990).   These   oxidatively 
modified products may affect several functions in 
cancer   cells   or   tumor   tissue   such   as   cell 
proliferation, promotion of mutations and genetic 
instability. Inherent oxidative stress is a potent 
factor of angiogenesis and is considered to be 
involved in patho-physiology of cancers (Kuroki et al 
1996).
Angiogenesis is a complex, dynamic process that 
involves multiple pathways that converge to affect 
carcinogenesis, proliferation, and tumor growth. 
During the process of tumor angiogenesis, many of 
growth   factors   secreted   by   the   tumor   cells, 
endothelial cells and supporting cells are required 
for the angiogenesis. There is now enough evidence 
that the growth of solid tumors is also angiogenesis 
dependent. The degree of angiogenic activity in a 
tumour can be determined directly by determining 
the degree of vascularization within that tumour, 
the intratumoural microvessel density or indirectly 
by assaying known angiogenic stimulatory factors. 
In addition to simulators many angiogenic inhibitors 
have been identified. Angiogenesis is a dynamic 
balance of angiogenic stimulators and inhibitors 
mediating   interactions   between   tumour   cells, 
endothelial cells, and the surrounding extra cellular 
matrix. Understanding these interactions and the 
various controls of angiogenesis such as oncogenes 
and hypoxic regulation, points to anti-angiogenesis 
becoming an extremely promising future therapy.
Many angiogenic factors have been identified 
such as VEGF, Fibroblast growth factors, Thymidine 
Phosphorylase/Platelet   derive   endothelial   cell 
growth   factor,   Angiogenin,   Heptocyte   growth 
factor,   interleukin-8,   Placental   growth   factor, 
Prostaglandin   E-1   and   E2,   transforming   growth 
factor, tumour necrosis factor-α. Elevated levels of 
angiogenic stimulators correlate with poor outcome 
in a number of tumours. Thymidine phosphorylase 
is an enzyme; it is also angiogenic and induces 
endothelial cell migration in vitro. Elevated levels of 
the   Thymidine   Phosphorylase   have   been 
demonstrated in many tumours including bladder, 
breast and ovarian cancers. 
The present study was undertaken in order to 
investigate   the   role   of   oxidative   stress   and 
expression of thymidine phosphorylase activity of 
cells   in   stimulating   angiogenesis   in   prostate 
carcinoma. In addition, thymidine phosphorylase 
expression was analysed for possible associations 
with histological grade and PSA expression.
MATERIALS AND METHODS
This study was conducted in Department of 
General   Medicine,   and   Department   of   Urology, 
University Hospital, Banaras Hindu University in 
collaboration   with   Department   of   Biophysics, 
Institute   of   Medical   Sciences,   Banaras   Hindu 
University. 
Selection of cases
Case   control   study   comprised   of   clinically 
suspected   and   histopathologically   confirmed   50 
cases of carcinoma prostate. Patients of suspected 
carcinoma   prostate   were   subjected   to   various 
investigations   such   as   Serum   Prostate   Specific 
Antigen titre, Transrectal ultrasound (TRUS), USG 
abdomen, TRUS biopsy, Bone Scan, Chest X-ray, CT 
scan abdomen. 
Collection of samples
5 ml of blood was collected by vene-puncture 
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with proper aseptic technique in a plain sterile vial. 
Serum   was   separated   by   centrifugation   at   low 
speed and stored at -70
0  degree until analyzed. 
Blood samples from the study subjects were taken 
with the informed consent of each individual purely 
for research purpose.
Estimation of Lipid Peroxidation level
Assay of oxidative damage in the serum of the 
patients as well as healthy control samples was 
assessed   by   measurement   of   products   of   lipid 
peroxidation in serum by the thiobarbituric acid 
(TBA) method (Burge and Aust, 1978). MDA, which 
is a stable end product of fatty acid peroxidation, 
reacts with TBA at acidic conditions to form a 
complex that has maximum absorbance at 532 nm.
Estimation of Thymidine phosphorylase (PDECGF) 
level 
Thymidine   phosphorylase  (TP)   ELISA   is   an 
enzyme   linked   immunosorbent   assay   for   the 
quantitative in vitro determination of natural and 
recombinant   human   Thymidine   phosphorylase 
(PDECGF) in research samples of tumor, lysates 
from tumor cell lines, peripheral blood cells, or 
serum   within   antibody   pre   coated   micro   titers 
plates (MTPs).
In the first step TP is bound to anti TP coated 
surface of the micro titer plate by taking 50 µl of 
standard   and   serum   samples   from   controls   / 
patients.   Following   the   washing   step,   the 
peroxidase (HRP) conjugated second antibody is 
added to the wells and the plate was incubated at 
room   temperature   for   one   hour   with   constant 
shaking. Following the washing step the peroxidase 
bound in the complex is developed by the substrate 
ABTS by mixing with 100 µl of sample buffer. The 
plate was incubated at room temp for one hour 
with constant shaking for the binding to the coated 
wells. The color intensity is proportional to the 
concentration of TP.
Statistical Methods
Study data was presented as percentage and 
Mean ±SD. Student ‘t’ test was used for the mean 
difference between two groups for unpaired cases. 
Chi-Square   was   used   to   test   significance   of 
difference among two proportions. The level of 
significance was considered at 5% as cut off point.
RESULTS 
Patients in the study group comprising of 50 
cases of carcinoma prostate along with twenty age 
and sex matched healthy subjects as controls were 
inducted the for study. Carcinoma prostate (Ca 
Prostate) had three subgroups: Adenocarcinoma, 
Transitional   cell   carcinoma   and   Squamous   cell 
carcinoma.  The age and sex wise analysis of the 
controls, cases and their subgroups did not reveal 
any statistical significant difference in distribution; 
thus   ruling   out   the   effect   of   sex   and   age   as 
confounding factors. 
The levels of Malondialdehyde in Carcinoma 
Prostate   group   were   found   to   be   elevated   in 
comparison to controls indicating the higher level of 
oxidative damage. The difference between these 
values was statistically significant as shown in Table 
1.  A significant increase in the activity of serum 
thymidine phosphorylase in the carcinoma prostate 
cases   in   comparison   to   controls   groups   was 
observed.  History of smoking revealed that only 
23%   patients   were   smokers,   this   signifies   that 
smoking may not be risk factor for prostate cancer. 
Most of the cases presented were of localized 
disease.
Serum   thymidine   phosporylase   measurement 
was   done   in   controls   and   prostate   carcinoma 
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patient   group   and   its   relationship   with   Clinical 
stage,   Gleason   score,   Prostate   volume,   Serum 
prostate specific antigen was investigated (Table 2). 
Significant difference (P < 0.001) in the activity of 
thymidine phosporylase in carcinoma prostate with 
respect to control groups indicates the role of 
thymidine phosphorylase  in carcinoma prostate. 
Serum thymidine phosphorylase was significantly 
higher in patients with metastasis prostate cancer 
in comparison to localized disease and healthy 
controls. PSA level greater than 20 ng /ml had 
significantly higher serum thymidine phosphorylase 
activity then the patients with PSA level < 20 ng / ml 
suggest   that   serum   thymidine   phosphorylase 
activity is elevated in disseminated disease. 
Table 1. Malondialdehyde status and Serum Thymidine Phosporylase (PD ECGF) Activity in study groups
Group MDA 
Mean± SD
(mmol/L)
p- value  Serum Thymidine Phosporylase 
(PD -ECGF) Activity
Mean± SD    (ng/ml)
p-value
Control (20) 1.12±0.38
0.001
253.29± 31.93
0.001 
Carcinoma Prostate (50) 3.138± 1.109 366.82±80.35
Table2. Serum Thymidine Phosporylase (PD ECGF) Activity in carcinoma Prostate patients with respect 
to tumour staging , PSA and Gleason score.
Group PDECGF Activity (ng/ml) p- value
Tumour Histology   
Adenocarcinoma (47)  361.26± 26.57 Non Significant
Squamous cell 
carcinoma (02)
351.37±24.15
Transitional   cell 
carcinoma (01)
342.22±21.74
Metastasis 
Negative  (32) 315.22± 52.44 < 0.001
Positive (18) 346.57± 76.25
PSA   (ng/ml)
  > 20  (14) 351.48±30.88 < 0.001  
  <  20  (36) 329.27±28.75
Gleason score
2-4  (26) 342.58± 24.67 0.218
5-7  (12) 346.37± 27.14  
8-10 (12) 349.26± 29.58
DISCUSSION
Prostate   cancer   is   the   consequence   of 
chromosomal   aberration   and   pathological 
proliferation of cells of the prostate tissue (Moul et 
al 2003). Although the specific etiological factors of 
prostate  cancer are not yet known, considerable 
evidence   indicate   that   both   genetic   and 
environment may play a role in the evolution of 
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prostate cancer. Angiogenesis, essential for tumor 
formation, can be measured by microvessel density 
and by measurement of circulating levels of related 
growth factors, such as  Thymidine phosphorylase 
(PD-   ECGF).  Several   studies   suggest   that   the 
measurement of circulating levels of PD- ECGF is a 
useful   tool   for   analyzing   prognosis   and   clinical 
outcome in many tumors.
Thymidine   phosphorylase   catalyses   the 
reversible phosphorylation of thymidine to thymine 
and 2-deoxy-D-ribose-1-phosphate (Fox et al 1995; 
Griffiths and Statford, 1997). The mechanism of the 
angiogenic activity is through generation of free 
radicals by the metabolic product 2-deoxy-D-ribose 
which   was   shown   to   stimulate   endothelial   cell 
migration   and   new   blood   vessel   formation 
(Moghaddam et al 1997; Brown and Bicknell 1998; 
Brown   et   al   2000).   The   free   radicals   activate 
expression of VEGF, interleukin- 8 (IL8) and matrix 
metalloproteinase-1 (MMP1) (Brown et al 2000).
In   the   present   study  age   distribution   of 
carcinoma prostate patients (68.32±9.32 years) was 
well   in   accordance   with   accepted   peak   age   of 
presentation;  most   of   the   patients   were   of 
adenocarcinoma and 2 of transitional cell and 1 of 
squmous cell carcinoma. This finding is consistent 
with the study (Randolph et al 1997) that > 95% of 
cancer prostate were of adenocarcinoma, in rest 5% 
Transitional cell carcinoma was more common then 
squmous   cell   carcinoma   and   other   types   like 
neuroendocrine type of carcinoma prostate. 
Serum   thymidine   phosporylase   activity  and 
oxidative stress levels were higher in patients with 
carcinoma   prostate   patients   than   controls. 
Additionally,   we  observed  significant  association 
between  serum   thymidine   phosporylase  and 
oxidative   stress   with   certain   clinico-pathologic 
factors   including   PSA,   Stage,   Metastasis   and 
Gleason score. Our study demonstrates a significant 
correlation   exist   between  Serum   thymidine 
phosporylase and oxidative stress levels in prostate 
carcinoma patients.  Significant difference in the 
activity of thymidine phosphorylase between the 
carcinoma prostate and control groups indicates 
thymidine phosphorylase has a role in the disease 
process.   Serum   Thymidine   phosphorylase   was 
significantly   higher   in   patients   with   metastasis 
prostate   cancer   in   comparison   to   patients   of 
localized disease and healthy controls. The above 
findings are similar to the results reported in other 
studies (Sugamoto et al, 1999, Weidner et al 1993). 
In   conclusion,  Thymidine   phosphorylase/ 
platelet-derived   endothelial   cell   growth   factor 
(TP/PD-ECGF)   is   a   potent   angiogenic   molecule 
stimulating   endothelial   cell   migration   and   new 
blood vessel formation (Moghadam et al, 1995). 
The   enzyme’s   angiogenic   activity   has   been 
consistently   shown   in   a   variety   of   human 
malignancies,   despite   variations   of   its   principal 
source   of   production.   High  thymidine 
phosphorylase expression was associated with high 
angiogenesis (Koukourakis et al, 1998). Sugamoto et 
al   (1999)   also   indicated   that  thymidine 
phosphorylase  levels   are   higher   in   prostate 
carcinomas   than   in   normal   prostatic   tissues. 
Thymidine   phosphorylase   may   be   a   target   for 
cytotoxic and antiangiogenic therapeutic strategies 
in prostate tumours.
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